Biliary Atresia
Oncology·MeSH: Biliary Atresia
Prevalence
5.0 / 100K
2 drugs in development·1 company·6 clinical trials
Drug Pipeline by Phase
Approved(1)
Phase 3(1)
| Drug | Company |
|---|---|
| oca | INTERCEPT PHARMACEUTICALS, INC. (ICPT) |
Compare drugs
Frequently asked questions
How many drugs are in development for Biliary Atresia?
BioSniper tracks 2 drugs in development for Biliary Atresia across 1 company.
How many clinical trials target Biliary Atresia?
There are 6 clinical trials targeting Biliary Atresia tracked by BioSniper.
What is the prevalence of Biliary Atresia?
The estimated prevalence of Biliary Atresia is approximately 5.0 per 100,000 population.
Deep-dive into Biliary Atresia
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis